The PE Ratio as of November 2024 (TTM) for Bio-Rad Laboratories, Inc. (BIO) is -11.86

According to Bio-Rad Laboratories, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -11.86. This represents a change of -403.04% compared to the average of 3.91 of the last 4 quarters.

Bio-Rad Laboratories, Inc. (BIO) Historical PE Ratio (quarterly & annually)

How has BIO PE Ratio performed in the past?

The mean historical PE Ratio of Bio-Rad Laboratories, Inc. over the last ten years is 34.45. The current -11.86 PE Ratio has changed -3542.43% with respect to the historical average. Over the past ten years (40 quarters), BIO's PE Ratio was at its highest in in the June 2017 quarter at 332.76. The PE Ratio was at its lowest in in the December 2016 quarter at -65.34.

Bio-Rad Laboratories, Inc. (BIO) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Bio-Rad Laboratories, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Bio-Rad Laboratories, Inc. (BIO) Average PE Ratio

How has BIO PE Ratio performed in the past?

The current PE Ratio of Bio-Rad Laboratories, Inc. (BIO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Bio-Rad Laboratories, Inc. (BIO) PE Ratio vs. Peers

How is BIO’s PE Ratio compared to its peers?

Bio-Rad Laboratories, Inc.’s PE Ratio is greater than Tandem Diabetes Care, Inc. (-15.93), less than DexCom, Inc. (42.17), less than Inspire Medical Systems, Inc. (170.64), less than ShockWave Medical, Inc. (76.34), less than Penumbra, Inc. (273.64), less than CONMED Corporation (17.55), less than Bruker Corporation (27.72), less than Zimmer Biomet Holdings, Inc. (20.58), greater than Glaukos Corporation (-52.99), greater than Inari Medical, Inc. (-36.88), less than Insulet Corporation (43.80), less than Globus Medical, Inc. (125.55), greater than NovoCure Limited (-12.81), less than STERIS plc (48.74), less than Anika Therapeutics, Inc. (-2.57), less than Integer Holdings Corporation (40.94),

Build a custom stock screener for Bio-Rad Laboratories, Inc. (BIO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bio-Rad Laboratories, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Bio-Rad Laboratories, Inc. (BIO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Bio-Rad Laboratories, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.